NCT00251134View on ClinicalTrials.gov

OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction

PHASE3CompletedINTERVENTIONAL
Enrollment

3,800

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

June 30, 2008

Study Completion Date

September 30, 2008

Conditions
Myocardial Infarction
Interventions
DRUG

Zodin (drug)

1 gram omega-3-acid ethyl esters 90 daily for a period of 12 months

DRUG

Olive oil (placebo)

1 gram olive oil daily for a period of 12 months

Trial Locations (10)

45138

Elisabeth-Krankenhaus, Essen

45661

Elisabeth-Krankenhaus, Recklinghausen

47228

Johanniter-Krankenhaus Rheinhausen, Duisburg

59494

Marienkrankenhaus, Soest

65929

Staedt. Kliniken Frankfurt/Main-Hoechst, Frankfurt am Main

67063

Klinikum der Stadt Ludwigshafen gGmbH, Ludwigshafen am Rhein

69120

Universitaetsklinikum Heidelberg, Heidelberg

85049

Klinikum Ingolstadt, Ingolstadt

90766

Klinikum Fuerth, Fürth

91413

Klinikum Neustadt, Neustadt/Aisch

Sponsors

Collaborators (1)

Pronova BioPharma
All Listed Sponsors
collaborator

Trommsdorff GmbH & Co. KG

INDUSTRY

collaborator

Pronova BioPharma

INDUSTRY

lead

Stiftung Institut fuer Herzinfarktforschung

OTHER

NCT00251134 - OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction | Biotech Hunter | Biotech Hunter